Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc.verified

TENX

Price:

$11.48

Market Cap:

$197.43M

Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary hypertension, particularly that linked to heart failure with preserved ejection fraction (HFpEF), as well as other forms of associated pulmonary hypertension. Additionally, the company is progressing TNX-201 (imatinib), a tyrosine kinase inhibitor, designed to treat pulmonary arterial h...[Read more]

Industry

Biotechnology

IPO Date

1994-04-04

Stock Exchange

NASDAQ

Ticker

TENX

The ROE as of June 2026 (TTM) for Tenax Therapeutics, Inc. (TENX) is -56.32%

According to Tenax Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -56.32%. This represents a change of 297.74% compared to the average of -14.16% of the last 4 quarters.

Tenax Therapeutics, Inc. (TENX) Historical ROE (quarterly & annually)

How has TENX ROE performed in the past?

The mean historical ROE of Tenax Therapeutics, Inc. over the last ten years is -252.29%. The current -56.32% ROE has changed -77.68% with respect to the historical average. Over the past ten years (40 quarters), TENX's ROE was at its highest in in the September 2024 quarter at -4.07%. The ROE was at its lowest in in the March 2021 quarter at -767.14%.

Quarterly (TTM)
Annual

Average

-252.29%

Median

-156.25%

Minimum

-765.06%

Maximum

-19.13%

Tenax Therapeutics, Inc. (TENX) ROE by Quarter and Year

Discovering the peaks and valleys of Tenax Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 999.54%

Maximum Annual ROE = -19.13%

Minimum Annual Increase = -87.13%

Minimum Annual ROE = -765.06%

Quarterly (TTM)
Annual
YearROEChange
2025-54.19%183.19%
2024-19.13%-79.91%
2023-95.22%-87.13%
2022-740.11%-3.26%
2021-765.06%259.22%
2020-212.98%-4.29%
2019-222.51%284.44%
2018-57.88%-41.84%
2017-99.53%-61.16%
2016-256.25%999.54%

Tenax Therapeutics, Inc. (TENX) Average ROE

How has TENX ROE performed in the past?

The current ROE of Tenax Therapeutics, Inc. (TENX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-56.18%

5-year avg

-334.74%

10-year avg

-252.29%

Tenax Therapeutics, Inc. (TENX) ROE vs. Peers

How is TENX’s ROE compared to its peers?

Tenax Therapeutics, Inc.’s ROE is greater than Verrica Pharmaceuticals Inc. (-1136.50%), less than SAB Biotherapeutics, Inc. (-0.29%), less than Q32 Bio Inc. (230.68%), greater than AN2 Therapeutics, Inc. (-52.35%), greater than Jasper Therapeutics, Inc. (-523.04%), greater than NextCure, Inc. (-186.96%), greater than Plus Therapeutics, Inc. (-198.48%), greater than Boundless Bio, Inc. (-53.60%), less than Pluri Inc. (203.55%), less than Minerva Neurosciences, Inc. (359.80%),

Build a custom stock screener for Tenax Therapeutics, Inc. (TENX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenax Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenax Therapeutics, Inc. (TENX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenax Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Tenax Therapeutics, Inc.'s ROE?

How is the ROE calculated for Tenax Therapeutics, Inc. (TENX)?

What is the highest ROE for Tenax Therapeutics, Inc. (TENX)?

What is the 3-year average ROE for Tenax Therapeutics, Inc. (TENX)?

What is the 5-year average ROE for Tenax Therapeutics, Inc. (TENX)?

How does the current ROE for Tenax Therapeutics, Inc. (TENX) compare to its historical average?